Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Other Operating Expenses (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Other Operating Expenses for 12 consecutive years, with $750000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Other Operating Expenses changed N/A year-over-year to $750000.0, compared with a TTM value of $750000.0 through Sep 2025, down 81.08%, and an annual FY2024 reading of $4.0 million, changed N/A over the prior year.
  • Other Operating Expenses was $750000.0 for Q1 2025 at Arcadia Biosciences, down from $4.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $4.0 million in Q2 2024 and bottomed at -$480000.0 in Q4 2021.
  • Average Other Operating Expenses over 5 years is $377583.3, with a median of $38500.0 recorded in 2022.
  • The sharpest move saw Other Operating Expenses crashed 132.76% in 2023, then surged 21152.63% in 2024.
  • Year by year, Other Operating Expenses stood at -$480000.0 in 2021, then surged by 85.0% to -$72000.0 in 2022, then soared by 50.0% to -$36000.0 in 2023, then skyrocketed by 11211.11% to $4.0 million in 2024, then crashed by 81.25% to $750000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for RKDA at $750000.0 in Q1 2025, $4.0 million in Q2 2024, and -$36000.0 in Q4 2023.